Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F48T2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,049
Award facts
- Contract value 100% obligated
- $19,048.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On February 4, 2026, the Defense Logistics Agency awarded a $19,048.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injections (0.5 ml). The contract, which carries no set-aside designation, was competitively awarded and has an ultimate completion date of February 5, 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which does business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The parent company holds an even larger IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, demonstrating Cencora's significant role in supplying essential pharmaceutical and medical commodities to federal agencies including the Defense Health Agency, U.S. Coast Guard, and Department of Veterans Affairs. The procurement of Zepbound, a diabetes medication, aligns with DLA's ongoing support of military treatment facilities and federal healthcare programs requiring specialty medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F48T2?
SPE2DR26F48T2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F48T2 worth?
The government has obligated $19,049 on SPE2DR26F48T2.
Is contract SPE2DR26F48T2 an order under another contract?
Yes. SPE2DR26F48T2 is a delivery order under SPE2DR25D3304, an indefinite delivery contract.
Was contract SPE2DR26F48T2 competed?
The extent of competition for SPE2DR26F48T2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award